Cargando…
Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report
BACKGROUND: Factor V (FV) deficiency is an extremely rare disease, with an incidence of 1 in 1 million. The bleeding symptoms are mild, and the prognosis is good; however, the safety of surgical treatment is unclear, because there are few available reports. Herein, we report a case of hepatocellular...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588126/ https://www.ncbi.nlm.nih.gov/pubmed/36271957 http://dx.doi.org/10.1186/s40792-022-01559-7 |
_version_ | 1784814058983129088 |
---|---|
author | Seki, Takaomi Tsukagoshi, Mariko Harimoto, Norifumi Araki, Kenichiro Watanabe, Akira Ishii, Norihiro Hagiwara, Kei Hoshino, Kouki Muranushi, Ryo Kakizaki, Satoru Ogawa, Yoshiyuki Handa, Hiroshi Shirabe, Ken |
author_facet | Seki, Takaomi Tsukagoshi, Mariko Harimoto, Norifumi Araki, Kenichiro Watanabe, Akira Ishii, Norihiro Hagiwara, Kei Hoshino, Kouki Muranushi, Ryo Kakizaki, Satoru Ogawa, Yoshiyuki Handa, Hiroshi Shirabe, Ken |
author_sort | Seki, Takaomi |
collection | PubMed |
description | BACKGROUND: Factor V (FV) deficiency is an extremely rare disease, with an incidence of 1 in 1 million. The bleeding symptoms are mild, and the prognosis is good; however, the safety of surgical treatment is unclear, because there are few available reports. Herein, we report a case of hepatocellular carcinoma with congenital FV deficiency in a patient who safely underwent laparoscopic hepatectomy. CASE PRESENTATION: A 79-year-old man, diagnosed with hepatocellular carcinoma of liver segment 5, with type C cirrhosis and sustained virological response visited our hospital. He had congenital FV deficiency, and blood tests showed coagulation deficiencies with an FV activity of < 2.6%, prothrombin time activity of 11%, and activated partial thromboplastin time of 100.3 s. Surgery and radiofrequency ablation were considered for treatment. Since the tumor was in contact with the Glissonean pedicle 5 + 6, surgery was judged to be superior from the viewpoint of safety and curability. After discussing the safety of the surgery with a hematologist, it was determined that the operation could be performed safely by transfusing sufficient fresh frozen plasma (FFP). Laparoscopic hepatic segment 5 + 6 subsegmental resection was performed with FFP transfusion, fluid restriction, airway pressure control, and central venous pressure reduction to control the bleeding. Bleeding was minimized during the transection of the liver parenchyma and no bleeding tendency was observed. The operative time was 445 min, and the amount of intraoperative bleeding was 171 mL. No complications, such as postoperative bleeding, were observed, and the patient was discharged on the eighth postoperative day. CONCLUSIONS: Liver surgery can be performed safely in FV-deficient patients with strict coagulation capacity monitoring and appropriate transfusion of FFP. Preoperative evaluation of cardiac function to determine tolerance to high doses of FFP and ingenuity of surgery and intraoperative management to minimize blood loss are important. |
format | Online Article Text |
id | pubmed-9588126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95881262022-10-24 Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report Seki, Takaomi Tsukagoshi, Mariko Harimoto, Norifumi Araki, Kenichiro Watanabe, Akira Ishii, Norihiro Hagiwara, Kei Hoshino, Kouki Muranushi, Ryo Kakizaki, Satoru Ogawa, Yoshiyuki Handa, Hiroshi Shirabe, Ken Surg Case Rep Case Report BACKGROUND: Factor V (FV) deficiency is an extremely rare disease, with an incidence of 1 in 1 million. The bleeding symptoms are mild, and the prognosis is good; however, the safety of surgical treatment is unclear, because there are few available reports. Herein, we report a case of hepatocellular carcinoma with congenital FV deficiency in a patient who safely underwent laparoscopic hepatectomy. CASE PRESENTATION: A 79-year-old man, diagnosed with hepatocellular carcinoma of liver segment 5, with type C cirrhosis and sustained virological response visited our hospital. He had congenital FV deficiency, and blood tests showed coagulation deficiencies with an FV activity of < 2.6%, prothrombin time activity of 11%, and activated partial thromboplastin time of 100.3 s. Surgery and radiofrequency ablation were considered for treatment. Since the tumor was in contact with the Glissonean pedicle 5 + 6, surgery was judged to be superior from the viewpoint of safety and curability. After discussing the safety of the surgery with a hematologist, it was determined that the operation could be performed safely by transfusing sufficient fresh frozen plasma (FFP). Laparoscopic hepatic segment 5 + 6 subsegmental resection was performed with FFP transfusion, fluid restriction, airway pressure control, and central venous pressure reduction to control the bleeding. Bleeding was minimized during the transection of the liver parenchyma and no bleeding tendency was observed. The operative time was 445 min, and the amount of intraoperative bleeding was 171 mL. No complications, such as postoperative bleeding, were observed, and the patient was discharged on the eighth postoperative day. CONCLUSIONS: Liver surgery can be performed safely in FV-deficient patients with strict coagulation capacity monitoring and appropriate transfusion of FFP. Preoperative evaluation of cardiac function to determine tolerance to high doses of FFP and ingenuity of surgery and intraoperative management to minimize blood loss are important. Springer Berlin Heidelberg 2022-10-22 /pmc/articles/PMC9588126/ /pubmed/36271957 http://dx.doi.org/10.1186/s40792-022-01559-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Case Report Seki, Takaomi Tsukagoshi, Mariko Harimoto, Norifumi Araki, Kenichiro Watanabe, Akira Ishii, Norihiro Hagiwara, Kei Hoshino, Kouki Muranushi, Ryo Kakizaki, Satoru Ogawa, Yoshiyuki Handa, Hiroshi Shirabe, Ken Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title | Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title_full | Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title_fullStr | Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title_full_unstemmed | Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title_short | Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report |
title_sort | laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor v deficiency: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588126/ https://www.ncbi.nlm.nih.gov/pubmed/36271957 http://dx.doi.org/10.1186/s40792-022-01559-7 |
work_keys_str_mv | AT sekitakaomi laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT tsukagoshimariko laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT harimotonorifumi laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT arakikenichiro laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT watanabeakira laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT ishiinorihiro laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT hagiwarakei laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT hoshinokouki laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT muranushiryo laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT kakizakisatoru laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT ogawayoshiyuki laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT handahiroshi laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport AT shirabeken laparoscopichepatectomyforhepatocellularcarcinomainapatientwithcongenitalfactorvdeficiencyacasereport |